This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Medtronic, Campbell: Premarket Trading

Stocks in this article: HPQ JCG JNJ LYG RBS MDT CPB TKC

(Premarket story updated with share price changes and earnings news from Medtronic and Campbell Soup.)
NEW YORK ( TheStreet) -- Medtronic (MDT) said second-quarter earnings fell 35% to $566 million, or 52 cents a share. On a non-GAAP basis, earnings rose 4% to $887 million, or 82 cents a share.

Analysts, on average, expected earnings of 81 cents a share.

Medtronic ended Monday's trading session up 0.3% at $34.70.

Campbell Soup (CPB) reported first-quarter earnings fell about 8% to $279 million, or 82 cents a share, from $304 million, or 87 cents a share, a year ago as U.S. soup sales fell. Shares of Campbell ended Monday 0.5% higher at $34.83.

Hewlett-Packard (HPQ) shares rose 2.2% to $44.19 in premarket trading Tuesday as the tech giant beat on both the fourth-quarter top and bottom lines and hiked its fiscal-year outlook.

Specialty retailer J. Crew (JCG) is reportedly close to being bought out by private-equity firms TPG Capital and Leonard Green & Partners for about $43.50 a share, or about $2.8 billion. Shares of J. Crew were surging by 22.2% to $46 in premarket trading.

Johnson & Johnson's (JNJ) McNeil Consumer Healthcare division is once again planning recalls, this time of Children's Benadryl allergy tablets and junior-strength Motrin caplets because of manufacturing problems. The division said the drugs were being recalled due to "insufficiencies in the development of the manufacturing process." Shares of J&J were trading down 0.6% to $63.25 in premarket trading.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs